For instance, the pioneering mouse models of BCR-ABL leukemia were associated with embryonic or early postnatal lethality, a stark contrast to the indolent behavior of CML in humans (Heisterkamp et al., 1990, 1991; Sawyers, 1999). This evidence concerns the gene ABL1 and leukemia.